The worldwide leading vitamin B12 manufacturer Hebei Yuxing was ordered by the Chinese local government to suspend production from November 29 onwards. On the one hand, the company had experienced an unannounced reexamination by authorities, which did not approve the waste discharge technology in regards to environmental pollution. On the other hand, the heating season in China has begun, forcing especially pharmaceuticals manufacturers and other major-polluting industries to suspend production in the winter months, when heating processes are already polluting the air significantly.
According to local Bureau of Environmental Protection in Hebei Province, the company Hebei Yuxing is only allowed to resume production after receiving the approval of authorities. An estimated time has not been announced yet.
China’s heating season
The heating season in the northern part of China, where Hebei Yuxing is located, is traditionally ranging from November to March. Hence, in this season, many high-polluting industries, like pharmaceuticals, are forced to suspend their production from the middle of November 2017 to the middle of March 2018, in order to counter the high pollution caused already by the heaters. Many enterprises are not allowed or only partly allowed to produce drugs and pharmaceutical products for about 4 months in total, which is one quarter of the year.
The vitamin B12 market has been growing at a significant rate in the ending year. As a result of the prosperous outlook, the market is also expecting huge investments in R&D from the government of the USA as well as from private firms over the coming years. This could create some serious competition for the market share of Hebei Yuxing.
The applications of vitamin B12 range from pharmaceuticals, food and beverages, over animal feed, to cosmetics. The available forms of vitamin B12 are multivitamins, B complex vitamins, and individual supplements.
CCM is the leading market intelligence provider for China’s agriculture, chemicals, and food and feed markets